NCT05880407 Pilot Study of Percutaneous Correction of Hallux Valgus
| NCT ID | NCT05880407 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Ortopedico Rizzoli |
| Condition | Hallux Valgus |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2022-02-22 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2022-02-22 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a pilot study with a randomized controlled design.
Eligibility Criteria
Inclusion Criteria: * Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment * HVA (hallux valgus angle): 20°-40° * IMA (intermetatarsal angle): 10°-20° Exclusion Criteria: * Patients with instability of the first metatarsophalangeal joint * Patients with severe morphostructural alterations or other pathologies in the foot and lower limb * patients requiring additional surgical procedures * patients with severe vascular and neurological systemic pathologies * systemic pathologies that may impair bone consolidation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05880407 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Hallux Valgus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05880407 currently recruiting?
Yes, NCT05880407 is actively recruiting participants. Contact the research team at lisa.berti@ior.it for enrollment information.
Where is the NCT05880407 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT05880407 clinical trial?
NCT05880407 is sponsored by Istituto Ortopedico Rizzoli. The trial plans to enroll 40 participants.